| Product Code: ETC8877828 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Antimicrobial Resistance Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Portugal Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Portugal Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Portugal Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Portugal Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Portugal Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Portugal Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antimicrobial-resistant infections in Portugal |
4.2.2 Rising awareness about the importance of antimicrobial stewardship |
4.2.3 Government initiatives to combat antimicrobial resistance |
4.3 Market Restraints |
4.3.1 Limited availability of effective antibiotics |
4.3.2 High cost associated with developing new antimicrobial drugs |
4.3.3 Lack of standardized guidelines for antimicrobial usage in healthcare settings |
5 Portugal Antimicrobial Resistance Market Trends |
6 Portugal Antimicrobial Resistance Market, By Types |
6.1 Portugal Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Portugal Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Portugal Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Portugal Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Portugal Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Portugal Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Portugal Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Portugal Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Portugal Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Portugal Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Portugal Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Portugal Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Portugal Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Portugal Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Portugal Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Portugal Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Portugal Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Portugal Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Portugal Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Portugal Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Portugal Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Portugal Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Portugal Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Portugal Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Portugal Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Portugal Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Portugal Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Portugal Antimicrobial Resistance Market Export to Major Countries |
7.2 Portugal Antimicrobial Resistance Market Imports from Major Countries |
8 Portugal Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage reduction in inappropriate antibiotic prescriptions |
8.2 Number of healthcare facilities implementing antimicrobial stewardship programs |
8.3 Rate of compliance with antimicrobial resistance guidelines |
8.4 Number of new antimicrobial resistance surveillance programs implemented |
9 Portugal Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Portugal Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Portugal Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Portugal Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Portugal Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Portugal Antimicrobial Resistance Market - Competitive Landscape |
10.1 Portugal Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Portugal Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here